Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Losses of chromosome 5q and 14q mark a subset of gastric cancers with good clinical outcome

ABSTRACT: Purpose: To improve clinical outcome of gastric cancer patients, most emphasis is on improving therapeutic regimens, including more extensive surgery as well as (neo)adjuvant chemotherapy. The present study set out to identify, based on DNA copy number profiling, subgroups of patients with different clinical outcomes who thus would qualify for different therapy intensities. Experimental Design: DNA of 206 gastric cancer patients was isolated and analyzed by genome wide array comparative genomic hybridization. DNA copy number profiles were evaluated and correlated to lymph node status and survival. In addition, HSP90 protein expression was analyzed and correlated to survival in 290 gastric cancer patients. Results: Frequent (>20%) DNA copy number gains were observed on chromosomes 1p, 6p, 7p, 7q, 8q, 11q, 12q, 13q, 16p, 16q, 17q, 19p, 19q, 20p, 20q, 21q and 22q, and losses on chromosomes 4p, 4q, 6p, 6q, 9p, 13q and 21q. Lymph node negative gastric cancers showed significantly more losses on chromosomes 5q11.2-q35.1, 10q11.23-21.3 and 14q32.11-q32.33. In addition, losses on 5q11.2-q31.3 and 14q32.11-q32.33 were highly correlated to good clinical outcome, in both lymph node negative and positive gastric cancer patients. Loss of expression of HSP90, located on chromosome 14q32.2, correlated to good survival time. Conclusion: Genome wide DNA copy number profiling allows to identify a subgroup of gastric cancers, marked by losses on chromosomes 5q11.2-q31.3 and 14q32.11-q32.33 that have an excellent clinical outcome after surgery alone, and patients with these tumors are unlikely to benefit from additional intensified therapies. Possible biological mechanisms could involve loss of heat shock proteins, of which the coding genes are located at these chromosomal regions. 183 gastric adenocarcinomas

ORGANISM(S): Homo sapiens

SUBMITTER: Oscar Krijgsman 

PROVIDER: E-GEOD-26389 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

<h4>Purpose</h4>To improve the clinical outcome of patients with gastric cancer, intensified combination strategies are currently in clinical development, including combinations of more extensive surgery, (neo)adjuvant chemotherapy, and radiotherapy. The present study used DNA copy number profiling to identify subgroups of patients with different clinical outcomes. We hypothesize that, by identification of subgroups, individual treatment strategies can be selected to improve clinical outcome and  ...[more]

Similar Datasets

Unknown Losses of chromosome 5q and 14q mark a subset of gastric cancers with good clinical outcome
2012-05-10 | GSE26389 | GEO
Transcriptomics Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers
2011-06-13 | E-GEOD-23418 | biostudies-arrayexpress
Transcriptomics Gastric cancers of Western European and African patients
2011-06-27 | E-GEOD-22789 | biostudies-arrayexpress
Transcriptomics Deletion of chromosome 4q predicts outcome in Stage II colon cancer
2010-07-13 | E-GEOD-17181 | biostudies-arrayexpress
Unknown Array CGH Analysis in primary gastrointestinal stromal tumors
2006-11-08 | GSE5336 | GEO
Unknown Identification of Acquired Copy Number Alterations and Uniparental Disomies in Cytogenetically Normal AML
2009-12-01 | GSE19101 | GEO
Unknown Genome-wide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance
2016-02-18 | GSE77975 | GEO
Transcriptomics Ten percent of aberrant cells is sufficient for detection of DNA copy number alterations (part 4)
2012-10-21 | E-GEOD-36991 | biostudies-arrayexpress
Transcriptomics Ten percent of aberrant cells is sufficient for detection of DNA copy number alterations (part 2)
2012-10-21 | E-GEOD-36986 | biostudies-arrayexpress
Transcriptomics Ten percent of aberrant cells is sufficient for detection of DNA copy number alterations (part 1)
2012-10-21 | E-GEOD-36856 | biostudies-arrayexpress